Literature DB >> 3783827

Translational requirement of La Crosse virus S-mRNA synthesis: in vivo studies.

R Raju, D Kolakofsky.   

Abstract

By using methods to isolate cytoplasmic RNAs which limit degradation, the effect of drugs which inhibit protein synthesis on the accumulation of La Crosse virus plus-strand S RNAs in vivo has been studied. Cycloheximide and puromycin treatment of infected cultures caused an abortive transcript of ca. 205 nucleotides (nt) to accumulate, whereas pactamycin led to the appearance of an RNA which was slightly shorter (ca. 200 nt). Both the 205- and 200-nt RNAs contained the same range of host primers at their 5' end, but their 3' ends mapped at ca. positions 175 and 165, respectively. Examination of the sequence in this region and at the mature mRNA termination site (position 886) suggests that the sequence YAAAAAT(A)GCAG is involved in transcription termination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3783827      PMCID: PMC255211     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Translational requirement of La Crosse virus S-mRNA synthesis: in vitro studies.

Authors:  C Bellocq; R Raju; J Patterson; D Kolakofsky
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

Review 2.  Bunyaviridae: recent biochemical developments.

Authors:  J F Obijeski; F A Murphy
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

3.  Determination of the gene sequence of poliovirus with pactamycin.

Authors:  D F Summers; J V Maizel
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

4.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

5.  Further studies on the inhibition of cellular protein synthesis by vesicular stomatitis virus.

Authors:  M C Jaye; W Godchaux; J Lucas-Lenard
Journal:  Virology       Date:  1982-01-15       Impact factor: 3.616

Review 6.  Priming of influenza viral RNA transcription by capped heterologous RNAs.

Authors:  R M Krug
Journal:  Curr Top Microbiol Immunol       Date:  1981       Impact factor: 4.291

7.  The use of thin acrylamide gels for DNA sequencing.

Authors:  F Sanger; A R Coulson
Journal:  FEBS Lett       Date:  1978-03-01       Impact factor: 4.124

Review 8.  Attenuation in the control of expression of bacterial operons.

Authors:  C Yanofsky
Journal:  Nature       Date:  1981-02-26       Impact factor: 49.962

9.  Peptidyl-puromycin synthesis on polyribosomes from Escherichia coli.

Authors:  S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  13 in total

1.  RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5' terminus of the negative-sense S segment.

Authors:  J C Osborne; R M Elliott
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Anti-mRNAs in La Crosse bunyavirus-infected cells.

Authors:  D Hacker; S Rochat; D Kolakofsky
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination.

Authors:  John N Barr
Journal:  RNA       Date:  2007-03-30       Impact factor: 4.942

4.  Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs.

Authors:  P Vialat; M Bouloy
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  La Crosse virus nucleocapsid protein controls its own synthesis in mosquito cells by encapsidating its mRNA.

Authors:  D Hacker; R Raju; D Kolakofsky
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  The translational requirement for complete La Crosse virus mRNA synthesis is cell-type dependent.

Authors:  R Raju; L Raju; D Kolakofsky
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  La Crosse virus infection of mammalian cells induces mRNA instability.

Authors:  R Raju; D Kolakofsky
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

8.  Translational requirement of La Crosse virus S-mRNA synthesis: in vitro studies.

Authors:  C Bellocq; R Raju; J Patterson; D Kolakofsky
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

9.  Translational requirement for La Crosse virus S-mRNA synthesis: a possible mechanism.

Authors:  C Bellocq; D Kolakofsky
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

10.  Analysis of La Crosse virus S-segment RNA and its positive-sense transcripts in persistently infected mosquito tissues.

Authors:  L J Chandler; L P Wasieloski; C D Blair; B J Beaty
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.